Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
NCT01703793
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Seborrheic Dermatitis
Interventions
DRUG:
Test Product 49778
DRUG:
Test Product 10156
DRUG:
Vehicle (placebo)
Sponsor
Medicis Global Service Corporation